Home › Occupations › Bioengineers and Biomedical Engineers › Princeton, NJ
Bioengineers and Biomedical Engineers in Princeton, NJ: H-1B salaries
29 labor condition applications for this occupation with a work site in Princeton, NJ. Median offered base salary $83,059; middle half $70,000–$110,000.
By wage level
| Wage level | Median salary |
|---|---|
| Level I (entry) | $70,000 |
| Level II (qualified) | $94,242 |
| Level III (experienced) | $145,000 |
| Level IV (fully competent) | $155,000 |
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Employers
| Employer | LCAs | Median salary |
|---|---|---|
| The Trustees of Princeton University | 15 | $70,000 |
| Bristol-Myers Squibb Company | 3 | $170,000 |
| TDL innovations, LLC. | 2 | $87,235 |
| Abbott Point of Care Inc. | 2 | $91,000 |
| Abbott Rapid Dx North America, LLC | 2 | $105,000 |
| Ori Biotech North America, Inc. | 1 | $80,000 |
| Siemens Medical Solutions USA, Inc. | 1 | $160,000 |
| EDDA Technology, Inc. | 1 | $150,000 |
| Complete Genomics LLC | 1 | $120,000 |
| Thermo Fisher Scientific Inc. | 1 | $140,000 |
Job titles
- Postdoctoral Research Associate10
- Associate Research Scholar3
- Scientist2
- Post-Market Surveillance Statistician2
- Senior Director, Corporate Development1
- Safety Scientist, Expedited Safety Reporting1
- Associate Bioengineer, Technical Solutions1
- Technical Support Specialist1
- Technical Manager1
- AIMLSPR6-AI/ML Scientist1
- Senior Manager, Strategy Implementation1
- Postdoctoral Research Associate/Fellow1
- Research Scientist1
- Bioengineer1
- Senior Technical Support Specialist1
H-1B sponsors in Princeton, NJ →
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).